Home Health Atara Biotherapeutics Announces Presentations Highlighting Tab-cel® and Mesothelin-Targeted CAR T Clinical Results...

Atara Biotherapeutics Announces Presentations Highlighting Tab-cel® and Mesothelin-Targeted CAR T Clinical Results at American Society of Clinical Oncology (ASCO) Annual Meeting – GlobeNewswire

4
0
SHARE



Atara Biotherapeutics Announces Presentations Highlighting Tab-cel® and Mesothelin-Targeted CAR T Clinical Results at American Society of Clinical Oncology (ASCO) Annual Meeting GlobeNewswire

SOUTH SAN FRANCISCO, Calif., May 15, 2019 (GLOBE NEWSWIRE) — Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell …



Source : https://globenewswire.com/news-release/2019/05/15/1825684/0/en/Atara-Biotherapeutics-Announces-Presentations-Highlighting-Tab-cel-and-Mesothelin-Targeted-CAR-T-Clinical-Results-at-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting.html

News Feed From news.google.com